ADR Monitoring in Children;Pancytopenia and Valproic Acid: A Dose-Related Phenomenon;Asterixis with Lithium Therapy?;Splenic Rupture Due to Subcutaneous Heparin;EPS on Clozapine?
Restricted accessResearch articleFirst published online August, 2000
ADR Monitoring in Children;Pancytopenia and Valproic Acid: A Dose-Related Phenomenon;Asterixis with Lithium Therapy?;Splenic Rupture Due to Subcutaneous Heparin;EPS on Clozapine?
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
Menniti-IppolitoF.Active monitoring of adverse drug reactions in children. The Lancet.2000; 355: 1613–24.
2.
OlubokaO.J., HaslamD., GardnerD.M.Pancytopenia and valproic acid: A dose-related phenomenon [letter]. J Amer Geriatric Society.2000; 48: 349–50.
3.
StewartJ.T., WilliamsL.S.A case of lithium asterixis. J Amer Geriatric Society.2000; 48: 457.
4.
WeissS.J.Spontaneous splenic rupture due to subcutaneous heparin therapy. J Emerg Med.2000; 18: 421–26.
5.
ElliottE.S.R., MarkenP.A., RuehterV.L.Clozapine-associated extrapyramidal reaction. Ann Pharmacother.2000; 34: 615–18.
